Compare iShares MSCI Malaysia ETF (EWM) vs Moderna, Inc. (MRNA) Price & Performance

iShares MSCI Malaysia ETFTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

iShares MSCI Malaysia ETF vs Moderna, Inc. — how do they compare? iShares MSCI Malaysia ETF trades at $28.29, while Moderna, Inc. trades at $61.7 (market cap $24.18B). Which is the better fit depends on your goals.

	EWM	MRNA
Sector	Broad Market / Factor	Health
52-Week High	$30.42	$81.80
52-Week Low	$24.73	$22.36
Market Cap	—	$24.18B
Enterprise Value	—	$20.33B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Malaysia ETF

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $59.81, up 1.08% today, with a bullish technical signal from moving averages and recent FDA approval for its mRNA flu vaccine mFLUSIVA. Despite beating Q2 2026 EPS estimates, revenue has declined from pandemic peaks, with a net income margin of -142.58% in 2026. The stock faces resistance near $61-$63, while support lies at $56-$59.

Outlook remains mixed; pipeline advancements in flu, Ebola, and oncology offer growth potential, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $54.33 price target below current levels, reflecting concerns over profitability amid transitioning business focus.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

About iShares MSCI Malaysia ETF

EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.